| 33.41 Data as of May 24 |  -0.02 / -0.06%Today’s Change | 20.25 Today|||52-Week Range 35.86 | +20.35% Year-to-Date |
| Previous close | 33.43 |
| Today’s open | 33.26 |
| Day’s range | 32.98 - 33.66 |
| Volume | 130,896 |
| Average volume (3 months) | 357,080 |
| Market cap | $2.0B |
| Dividend yield | -- |
| Earnings growth (last year) | +142.11% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +17.90% |
| P/E ratio | 34.8 |
| Price/Sales | 1.49 |
| Price/Book | 2.67 |
| Today’s change | Today’s % change | |
|---|---|---|
| CRLCharles River Labora... | +0.04 | +0.09% |
| ALNYAlnylam Pharmaceutic... | +0.92 | +3.28% |
| ABCOAdvisory Board Co | +0.19 | +0.38% |
| ISISIsis Pharmaceuticals... | +0.34 | +1.65% |
| Next reporting date | July 24, 2013 |
| EPS forecast (this quarter) | $0.38 |
| Annual revenue (last year) | $1.1B |
| Annual profit (last year) | $55.4M |
| Net profit margin | 4.97% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chief Executive Officer & Executive Director Ciaran Murray |
Chief Financial Officer & Head-Investor Relations Brendan Brennan |
Corporate headquarters Dublin, Dublin |
.
